[Edaily Reporter Shin Ha-yeon ] Global medical imaging solutions company DRGEM CORPORATION(263690)announced on the 22nd that it has signed a medical device supply contract worth 19,259,280,000 won with a Turkish company.
The contract period runs from July 21, 2026, to December 20, 2026. The identity of the contracting party and the product names were not disclosed to protect trade secrets. The contract value represents 18.74% of the company’s 2025 revenue. The company explained that this contract was secured through a global competitive bidding process and reflects a comprehensive evaluation of its technological capabilities, quality competitiveness, price competitiveness, and stable production and supply capacity.
Park Jeong-byeong, CEO of DRGEM CORPORATION, stated, “This contract is a meaningful achievement secured through competition with major global companies, based on DRGEM CORPORATION’s technological capabilities, quality competitiveness, and customer trust.” He added, “Moving forward, we will continue to pursue research and development and quality innovation based on our core values of ‘Quality, Value, Support’ to supply medical imaging diagnostic equipment that earns our customers’ trust.”
Meanwhile, DRGEM CORPORATION is also working to strengthen its product competitiveness to expand its global market presence. Its mobile X-ray system, “RAYMO,” received U.S. Food and Drug Administration (FDA) 510(k) clearance in May and obtained certification under the European Medical Device Regulation (CE MDR) in June.
“Now, when structuring a deal, we must consider not only whether the structure is legally feasible, but also whether we can explain it in a way that allows us to defend it before the board of director…
SK hynix has drawn a clear line regarding reports that it is pursuing the sale of its stake in its Chongqing, China, plant, stating, “Nothing has been finalized.” This is the company’s response to a r…
Regulatory authorities in South Korea and the United States have reached differing conclusions regarding “JointStem,” a stem cell therapy for degenerative knee osteoarthritis developed by NATURECELL C…